Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study

Peer Review reports

Original Submission
24 Mar 2021	Submitted	Original manuscript
18 Apr 2021	Reviewed	Reviewer Report
26 Apr 2021	Reviewed	Reviewer Report - David Taylor
30 Apr 2021	Reviewed	Reviewer Report
7 Jul 2021	Author responded	Author comments - Henry A. Nasrallah
Resubmission - Version 2
7 Jul 2021	Submitted	Manuscript version 2
15 Jul 2021	Author responded	Author comments - Henry A. Nasrallah
Resubmission - Version 3
15 Jul 2021	Submitted	Manuscript version 3
20 Jul 2021	Author responded	Author comments - Henry A. Nasrallah
Resubmission - Version 4
20 Jul 2021	Submitted	Manuscript version 4
27 Jul 2021	Reviewed	Reviewer Report
27 Jul 2021	Reviewed	Reviewer Report - David Taylor
Resubmission - Version 5
	Submitted	Manuscript version 5
Publishing
5 Aug 2021	Editorially accepted
8 Oct 2021	Article published	10.1186/s12888-021-03420-x

Back to article page